Mersana signs deal with Merck KGaA for cancer therapy development
(Reuters) – Mersana Therapeutics Inc said on Thursday it had signed a deal for developing cancer drugs with Germany’s Merck KGaA that has the potential to generate up to $800…
(Reuters) – Mersana Therapeutics Inc said on Thursday it had signed a deal for developing cancer drugs with Germany’s Merck KGaA that has the potential to generate up to $800…